
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/"  version="2.0">

<channel>
	<title>Oncology News, Insights, Stories by OncoDaily</title>
	<link>https://oncodaily.com</link>
	<description>Oncology News, Cancer Research &#38; Clinical Insights</description>
	<lastBuildDate>Thu, 07 May 2026 04:37:29 +0000</lastBuildDate>
	<language>en-US</language>
	<ttl>10</ttl>
	<copyright><![CDATA[P53 Inc.]]></copyright>
	<generator>Oncodaily.com</generator>
	<image>
		<url>https://oncodaily.com/pub/themes/oncodailynews/img/logo-ODN-round.png</url>
		<title>OncoDaily News</title>
		<link>https://oncodaily.com</link>
	</image>

	
<image>
	<url>https://oncodaily.com/pub/uploads/2025/10/OD-favicon-blank-320x320.webp</url>
	<title>Oncology News, Insights, Stories by OncoDaily</title>
	<link>https://oncodaily.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Immunoradiotherapy With Nivolumab in High-Risk Prostate Cancer</title>
		<link>https://oncodaily.com/oncolibrary/nivolumab-prostate-cancer</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/05/IMG_4533-1280x720.webp" />
		<pubDate>Thu, 07 May 2026 04:37:29 +0000</pubDate>
		<guid isPermaLink="false">97744b7ae7c0df5ecd5083af9b7d3317</guid>
				<category><![CDATA[Oncolibrary]]></category>
		<category><![CDATA[Immune Oncology]]></category>
		<category><![CDATA[ADT]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[high-risk cancer]]></category>
		<category><![CDATA[nivolumab prostate cancer]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[OncoDaily IO]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[radiotherapy]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/05/IMG_4533-1280x720.webp"/> <br/> <br/> Grade group 5 (GG5) prostate cancer represents one of the most aggressive disease subsets, associated with high rates of biochemical recurrence and metastatic progression despite standard-of-care (SOC) treatment. While androgen [&#8230;]]]></description>
							</item>
		<item>
		<title>Maria Hafez: Key Takeaways from ESMO Breast Berlin on HR+ Disease</title>
		<link>https://oncodaily.com/voices/maria-hafez-497628</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/01/OncoDaiy-Maria-Hafez-1-1280x720.webp" />
		<pubDate>Thu, 07 May 2026 02:53:05 +0000</pubDate>
		<guid isPermaLink="false">b0b034f0a068d67dffa414bf75b96a57</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[ESMO Breast]]></category>
		<category><![CDATA[ESMO Breast Berlin]]></category>
		<category><![CDATA[Maria Hafez]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[St. Luke's University Health Network]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/01/OncoDaiy-Maria-Hafez-1-1280x720.webp"/> <br/> <br/> Maria Hafez, Assistant Professor at St. Luke’s University Health Network, shared a post on X: &#8220;From ESMO Breast Berlin, the key message in HR+/HER2. Metastatic breast cancer is no longer [&#8230;]]]></description>
							</item>
		<item>
		<title>Amol Akhade: Esmo Breast 2026 &#8211; LBAs are Out . What&#8217;s the New Data from Destiny Breast 11?</title>
		<link>https://oncodaily.com/voices/amol-akhade-497599</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2025/11/Image-7-3-1280x720.jpeg" />
		<pubDate>Thu, 07 May 2026 02:48:43 +0000</pubDate>
		<guid isPermaLink="false">e5573df93a5764ecc154f258ad917cb8</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[Amol Akhade]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Destiny Breast 11]]></category>
		<category><![CDATA[ESMO Breast 2026]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2025/11/Image-7-3-1280x720.jpeg"/> <br/> <br/> Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on X: &#8220;Esmo Breast 2026 &#8211; LBAs are out . What&#8217;s the [&#8230;]]]></description>
							</item>
		<item>
		<title>Securing EU Investment for European Cancer Care and Health Systems &#8211; WECAN</title>
		<link>https://oncodaily.com/voices/wecan-497435</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/05/WECAN-1280x720.webp" />
		<pubDate>Thu, 07 May 2026 02:42:14 +0000</pubDate>
		<guid isPermaLink="false">36096a702d760e0ee0b8043d96fea7ff</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[WECAN]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/05/WECAN-1280x720.webp"/> <br/> <br/> WECAN shared a post by OncoDaily on LinkedIn, adding: ”Cancer cannot wait! We welcome the OncoDaily post highlighting this important moment for Europe’s cancer response. Recent developments in the European [&#8230;]]]></description>
							</item>
		<item>
		<title>Congratulations To Steven O’Day On Being Named Chair Of The OncoDaily World Melanoma Day 2026 Symposium &#8211; Agenus</title>
		<link>https://oncodaily.com/voices/agenus-497420</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2024/10/image001-2-1100x733-1.jpg" />
		<pubDate>Thu, 07 May 2026 02:37:06 +0000</pubDate>
		<guid isPermaLink="false">30c285f9bad3966f14befe65189a356f</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[Agenus]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Melanoma]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Steven O'Day]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2024/10/image001-2-1100x733-1.jpg"/> <br/> <br/> Agenus shared a post by OncoDaily on LinkedIn, adding: &#8220;Congratulations to Steven O&#8217;Day, Chief Medical Officer at Agenus, on being named Chair of OncoDaily’s World Melanoma Day 2026 Global Symposium. [&#8230;]]]></description>
							</item>
		<item>
		<title>Advancing Early Detection Through SpotTheDrop &#8211; Kenyan Network of Cancer Organizations</title>
		<link>https://oncodaily.com/voices/kenyan-network-of-cancer-organizations-497414</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2025/11/650eb12d9a5407e694257f8f_KENCO_11zon-1.jpg" />
		<pubDate>Thu, 07 May 2026 02:33:03 +0000</pubDate>
		<guid isPermaLink="false">3b6cf6e402f021c3fe1c2558071b0607</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Kenyan Network of Cancer Organizations]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2025/11/650eb12d9a5407e694257f8f_KENCO_11zon-1.jpg"/> <br/> <br/> Kenyan Network of Cancer Organizations shared a post on LinkedIn: ”This Bladder Cancer Month 26, learning about bladder cancer can also be interactive. World Bladder Cancer Patient Coalition invites you [&#8230;]]]></description>
							</item>
		<item>
		<title>Cesaltina Lorenzoni: Max Parkin Awarded for Transforming Cancer Surveillance and Research in Africa</title>
		<link>https://oncodaily.com/voices/cesaltina-lorenzoni-497400</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/05/IMG_0725.webp" />
		<pubDate>Thu, 07 May 2026 02:25:04 +0000</pubDate>
		<guid isPermaLink="false">ca760dce27f11a64331abb8d62249c37</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cesaltina Lorenzoni]]></category>
		<category><![CDATA[Max Parkin]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/05/IMG_0725.webp"/> <br/> <br/> Cesaltina Lorenzoni, Director at Maputo Central Hospital, Head Of National Cancer Control Programme, shared a post on LinkedIn: ”Lifetime Contribution to Cancer Surveillance and Research Award It is with great [&#8230;]]]></description>
							</item>
		<item>
		<title>Cancer Care in Europe From Strategy to Delivery &#8211; All.Can International</title>
		<link>https://oncodaily.com/voices/all-can-international-497373</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/01/Screenshot-2026-01-07-163453-1.webp" />
		<pubDate>Thu, 07 May 2026 02:21:27 +0000</pubDate>
		<guid isPermaLink="false">1bcd84314dd76c719544d3135b61febf</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[Alex Filicevas]]></category>
		<category><![CDATA[All.Can International]]></category>
		<category><![CDATA[Bettina Borisch]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Caroline Berchet]]></category>
		<category><![CDATA[Kelly Butterworth]]></category>
		<category><![CDATA[Kostas Athanasakis]]></category>
		<category><![CDATA[Marc Van Den Bulcke]]></category>
		<category><![CDATA[Nicholas Papandreou]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/01/Screenshot-2026-01-07-163453-1.webp"/> <br/> <br/> All.Can International shared a post on LinkedIn: ”Cancer systems across Europe are under pressure! Rising incidence, workforce shortages and financial constraints demand smarter implementation, not just stronger commitments. On 02 [&#8230;]]]></description>
							</item>
		<item>
		<title>Kefah Mokbel: Real-World Outcomes Diverge from KEYNOTE-522 in Early-Stage Triple-Negative Breast Cancer</title>
		<link>https://oncodaily.com/voices/kefah-mokbel-497592</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2025/10/OncoDaily-Kefah-Mokbel43.png" />
		<pubDate>Thu, 07 May 2026 02:17:43 +0000</pubDate>
		<guid isPermaLink="false">a890096fb02b3c3dab9012d722fbfe6f</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[Andrew A Davis]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Farah Raheem]]></category>
		<category><![CDATA[Jerline Hsin]]></category>
		<category><![CDATA[Katherine Clifton]]></category>
		<category><![CDATA[Kefah Mokbel]]></category>
		<category><![CDATA[Lauren Lyons]]></category>
		<category><![CDATA[Mara Lacy Hofherr]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Shawna Kraft]]></category>
		<category><![CDATA[Spenser January]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2025/10/OncoDaily-Kefah-Mokbel43.png"/> <br/> <br/> Kefah Mokbel, Chair of Breast Cancer Surgery at London Breast Institute and Honorary Professor of Medicine at Cardiff University School of Medicine, shared a post on LinkedIn: &#8220;Real-World Outcomes Diverge from KEYNOTE-522 [&#8230;]]]></description>
							</item>
		<item>
		<title>International Cooperation at the Heart of SIOP Europe 2026 &#8211; SIOP</title>
		<link>https://oncodaily.com/voices/siop-497580</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/05/51sx.webp" />
		<pubDate>Thu, 07 May 2026 02:14:37 +0000</pubDate>
		<guid isPermaLink="false">cd45b2f1f57739dc813e00f6895f91e8</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Glasgow]]></category>
		<category><![CDATA[International Society of Paediatric Oncology]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[SIOP]]></category>
		<category><![CDATA[SIOP Europe 2026]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/05/51sx.webp"/> <br/> <br/> International Society of Paediatric Oncology (SIOP), shared a post on LinkedIn: &#8220;We&#8217;re at SIOP Europe 2026 in Glasgow meeting lots of partners, members and friends. Come and visit the SIOP [&#8230;]]]></description>
							</item>
	</channel>
</rss>
